Sentien Biotechnologies Company
Sentien is a developer of new blood conditioning therapies designed to restore balance to the immune system of critically ill patients.
Industry:
MedTech
Headquarters:
Lexington, Massachusetts, United States
Founded Date:
2008-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Total Funding:
15134999
Last Funding Type:
Series A
Register and Claim Ownership